Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | PTPRB | P23467 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.35 |
| ▸ | JAK2 | O60674 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | CGAS | Q8N884 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oteracil SCHEMBL4648864 | 0.98 | LMNA (0.95) | LMNATSHRKDM4ECYP3A4CYP2C9 | |
| Oteracil SCHEMBL29572271 | 0.98 | LMNA (0.95) | LMNATSHRKDM4ECYP3A4CYP2C9 | |
| SCHEMBL15769086 | 0.79 | LMNA (0.65) | LMNATSHRSLC6A5POLB | |
| SCHEMBL3114000 | 0.75 | — | — | |
| Water SCHEMBL15331255 | 0.73 | LMNA (0.58) | LMNATSHRKDM4ECYP3A4CYP2C9 | |
| SCHEMBL11254727 | 0.73 | LMNA (0.57) | LMNATSHRKDM4ECYP3A4CYP2C9 | |
| SCHEMBL3085104 | 0.69 | LMNA (0.52) | LMNAKDM4ECYP3A4CYP2C9PTPRB | |
| SCHEMBL14072016 | 0.62 | LMNA (0.45) | LMNATSHRKDM4ECYP3A4CYP2C9 | |
| SCHEMBL10752092 | 0.62 | LMNA (0.44) | LMNAKDM4ECYP3A4CYP2C9PTPRB | |
| SCHEMBL22783664 | 0.62 | JAK2 (0.61) | LMNAKDM4EHSD17B10ALDH1A1JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2131 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720132-A1 | COMBINATION THERAPIES INVOLVING CLAUDIN 18.2 ANTAGONISTS FOR TREATMENT OF CANCER | Suzhou Transcenta Therapeutics Co., Ltd. (CN) | 2026-04-08 | — | — | EP | claimed |
| US-12595232-B2 | DRG-MDM2-1 for use as a novel Mouse Double Minute 2 (MDM2) inhibitor | BAHCESEHIR UNIVERSITESI (TR) | 2026-04-07 | — | — | US | claimed |
| US-20260078184-A1 | LAG-3 COMBINATION THERAPY FOR THE TREATMENT OF CANCER | BRISTOL-MYERS SQUIBB COMPANY (US) | 2026-03-19 | — | — | US | claimed |
| US-12576077-B2 | Composition for preventing, alleviating or treating cancer | CKP THERAPEUTICS, INC. (US) | 2026-03-17 | — | — | US | claimed |
| EP-4667493-A2 | LAG-3 COMBINATION THERAPY FOR THE TREATMENT OF CANCER | Bristol-Myers Squibb Company (US) | 2025-12-24 | — | — | EP | claimed |
| US-12502392-B2 | DRG-MDM2-6 for use as a novel mouse double minute 2 (MDM2) inhibitor | BAHCESEHIR UNIVERSITESI (TR) | 2025-12-23 | — | — | US | claimed |
| US-12435074-B2 | Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor | BAHCESEHIR UNIVERSITESI (TR) | 2025-10-07 | — | — | US | claimed |
| EP-3957631-B1 | QUINOLINE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR TREATING EWING'S SARCOMA | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) | 2025-09-10 | — | — | EP | claimed |
| US-12398128-B2 | Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor | BAHCESEHIR UNIVERSITESI (TR) | 2025-08-26 | — | — | US | claimed |
| EP-4602049-A1 | SOS1 INHIBITORS | Bayer Aktiengesellschaft (DE) | 2025-08-20 | — | — | EP | claimed |
| US-5763280-A | LYSING WITH A SURFACTANT; COMBINING WITH LIGAND TO FORM A STABLE CHROMOGEN WITH HEMOGLOBIN | COULTER INTERNATIONAL CORP. (US) | 1998-06-09 | — | — | US | claimed |
| US-5525603-A | MIXTURE OF 2,4-DIHYDROXYPYRIDINE COMPOUND AND OXONIC ACIDADMINISTERED WITH TEGAFUR; SIDE-EFFECT REDUCTION | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1996-06-11 | — | — | US | claimed |
| EP-0443028-B1 | NON-INJECTION CARCINOSTATIC AGENT FOR SUPPRESSING OCCURRENCE OF INFLAMMATION DUE TO 5-FLUOROURACIL AND METHOD FOR CURING CANCER | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-09-29 | — | — | EP | claimed |
| EP-0543015-A1 | COMPOSITION, METHOD AND KIT FOR POTENTIATING ANTITUMOR ACTIVITY AND FOR CURING TUMOR | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1993-05-26 | — | — | EP | claimed |
| US-5116600-A | Oxonic acid | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-05-26 | — | — | US | claimed |
| EP-0445239-A4 | ANTI-MALARIAL COMPOSITION AND METHOD OF USE | — | 1992-03-25 | — | — | EP | claimed |
| EP-0445239-A1 | ANTI-MALARIAL COMPOSITION AND METHOD OF USE | THE CATHOLIC UNIVERSITY OF AMERICA (US) | 1991-09-11 | — | — | EP | claimed |
| EP-0443028-A1 | NON-INJECTION CARCINOSTATIC AGENT FOR SUPPRESSING OCCURRENCE OF INFLAMMATION DUE TO 5-FLUOROURACIL AND METHOD FOR CURING CANCER | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-08-28 | — | — | EP | claimed |
| WO-1991000081-A2 | ANTI-MALARIAL COMPOSITION AND METHOD OF USE | THE CATHOLIC UNIVERSITY OF AMERICA (US) | 1991-01-10 | — | — | WO | claimed |
| US-4329381-A | Method for providing corrosion resistance to metal objects | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 1982-05-11 | — | — | US | claimed |